IMed Consultancy Limited

Activities: Regulatory

IMed Consultancy’s team of highly skilled and experienced medical regulatory professionals offers an outstanding yet accessible global regulatory service. We are committed to our team, to innovation, to our client’s growth and success, to the health tech community, and patients.

Visit website

Profile

Founded in 2012, IMed Consultancy offers a wide range of expert services to the global medical and health technology industry. We support medical device and in vitro medical device manufacturers to drive innovation, improve patient care and outcomes worldwide, providing assistance through all stages of the product lifecycle from: from concept and design through clinical studies and post-market surveillance.

IMed Consultancy’s team of highly skilled and experienced medical regulatory professionals offers an outstanding yet accessible global regulatory service. We are committed to our team, to innovation, to our client’s growth and success, to the health tech community, and patients. We build trusted relationships by offering agile solutions and education to advance healthcare innovations and adapting flexibly to client needs as we strive to stay ahead of industry trends, investing in developing our knowledge and seeking new opportunities to deliver value to the sector. With over 70 years of combined hands-on problem-solving expertise, our remit is truly global, ensuring that client devices are successfully launched and maintained in total compliance in the UK, EU and internationally.

For more information visit  www.imedconsultancy.com 

LinkedIn

 

Trending Articles

  1. Ardena to expand US footprint with the acquisition of advanced drug product manufacturing facility from Catalent Ardena, a specialist pharmaceutical CDMO with GMP facilities in Belgium, Spain, the Netherlands and Sweden, has signed a definitive agreement to acquire Catalent’s...
  2. Nuclera raises $75m to bolster its protein discovery platform The eProtein Discovery system is designed to speed up protein expression and purification by automating construct screening
  3. Thermo Fisher Scientific launches ambient antibody packaging shipping solution The new sustainable packaging solution allows the ambient distribution of therapeutic antibodies to customers
  4. Natac obtains the GMP certificate to manufacture for the pharmaceutical sector The GMP certificate will allow the manufacturing site in Hervás, Cáceres to manufaacture active ingredients for the pharmaceutical industry that is based on medicinal plants
  5. Maximise your automatic filling process in hazardous areas Discover how the IND500x ensures both safety and productivity in Zone 1/21 environments

Upcoming event

Lab Innovations

30-31 October 2024 | Exhibition | Birmingham, UK See all

Related Content

Medical Devices

IMed Consultancy shares IVD tips as the EU deadline for Class D devices draws closer

The whitepaper will analyse the role of in-vitro diagnostics (IVDs) in supporting healthcare systems with early disease diagnosis
Pharma 5.0

Unlocking potential through regulation: the AI revolution in medical devices

The healthcare industry is entering a transformative era with the emergence of digital technologies. Innovations such as wearable sensors to monitor vital signs and AI-powered diagnostic tools are poised to revolutionise healthcare delivery. However, navigating the evolving regulatory landscape remains a significant challenge
Regulatory

IMed launches new whitepaper exploring regulatory challenges for AI and ML in medical devices and digital health products

IMed Consultancy shares free paper assessing the regulatory state of play for artificial intelligence (AI) and machine learning (ML)-powered medical devices in the UK, US and EU
Regulatory

The key role of IVDs in healthcare: challenges to commercialisation and access

In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and infections, provide patients with a better understanding of their ailment and how it might be managed and changed with treatment
Regulatory

The entry conundrum for every medical device: which market first?

Regulatory bodies around the world are tackling the concerns raised by new technologies as well as seeking ways to accelerate the opportunities they provide to support patients, reports Leeanne Baker, Managing Director and Senior QA/RA Consultant at IMed Consultancy
Regulatory

Unlocking opportunities: entering the UK medical device market successfully

In the changing landscape of European medical device regulations, the UK remains an attractive destination for US and foreign businesses. Unlike the European Union (EU), the UK continues to operate within its consolidated regulatory framework, thereby positioning itself as an ideal market for novel and niche products
Subscribe now